HCW Biologics (HCWB) Long-Term Investments (2020 - 2025)
Historic Long-Term Investments for HCW Biologics (HCWB) over the last 6 years, with Q3 2025 value amounting to $1.3 million.
- HCW Biologics' Long-Term Investments fell 1709.15% to $1.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 million, marking a year-over-year decrease of 1709.15%. This contributed to the annual value of $1.6 million for FY2024, which is 1.56% down from last year.
- Latest data reveals that HCW Biologics reported Long-Term Investments of $1.3 million as of Q3 2025, which was down 1709.15% from $3.3 million recorded in Q2 2025.
- In the past 5 years, HCW Biologics' Long-Term Investments registered a high of $11.6 million during Q3 2021, and its lowest value of $1.3 million during Q3 2025.
- For the 5-year period, HCW Biologics' Long-Term Investments averaged around $4.4 million, with its median value being $1.6 million (2022).
- Its Long-Term Investments has fluctuated over the past 5 years, first surged by 62012.81% in 2021, then crashed by 8611.57% in 2022.
- HCW Biologics' Long-Term Investments (Quarter) stood at $11.5 million in 2021, then plummeted by 86.12% to $1.6 million in 2022, then increased by 0.02% to $1.6 million in 2023, then dropped by 0.02% to $1.6 million in 2024, then decreased by 17.09% to $1.3 million in 2025.
- Its Long-Term Investments stands at $1.3 million for Q3 2025, versus $3.3 million for Q2 2025 and $1.6 million for Q1 2025.